Ligand validation:7MGO

FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7MGO_FDA_B_601	86%	24%	0.084	0.952	1.87	1.29	14	8	2	0	100%	1
7MGO_FDA_A_601	68%	24%	0.111	0.923	1.84	1.29	11	7	2	0	100%	1
7MGN_FDA_A_602	62%	53%	0.137	0.93	0.8	1.03	2	6	1	0	100%	0.6808
4OPD_FDA_B_501	100%	67%	0.02	0.995	0.55	0.71	-	1	2	0	100%	1
3TSH_FDA_A_601	100%	38%	0.04	0.992	1.03	1.38	3	6	3	0	100%	1
3ATR_FDA_A_501	100%	23%	0.039	0.986	1.34	1.81	5	16	1	0	100%	1
4MOF_FDA_A_801	100%	19%	0.04	0.983	1.62	1.84	14	15	1	0	100%	1
7AA2_FDA_B_701	100%	55%	0.044	0.987	0.85	0.89	2	2	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.